All In Biotech

Drug Trial Radar · NCT06157450

Pharmacokinetics of ZSP1273 in Elder Participants

A Phase I Single Dose, Non-Randomised, Open-Label, Parallel Group Study to Investigate Pharmacokinetics, Safety and Tolerability of ZSP1273 in Elder Participants

Last checked: Nov 19, 2026Latest source record: Dec 5, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

32

Actual

Start

Oct 11, 2023

Primary completion

Nov 1, 2023

Study completion Nov 17, 2023

Sponsor

Sponsor type
Industry
First posted
Dec 5, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Basic science
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess the safety, tolerability and PK of ZSP1273 in elder Participants

Conditions

  • Elder

Interventions

  • ZSP1273Drug

    Participants receive ZSP1273 orally.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Maximum observed plasma concentration (Cmax)Time frame: Day 1 to Day 5
  2. Area under the concentration-time curve from time zero to infinity (AUCinf)Time frame: Day 1 to Day 5
  3. Area under the concentration-time curve from time zero to last time of quantifiable concentration (AUClast)Time frame: Day 1 to Day 5

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Sir Run Run Hospital

    Nanjing, Jiangsu, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.